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yosin VI (Myo6) is an actin-based motor protein
implicated in clathrin-mediated endocytosis in
nonneuronal cells, though little is known about
its function in the nervous system. Here, we ﬁnd that
Myo6 is highly expressed throughout the brain, local-
ized to synapses, and enriched at the postsynaptic
density. Myo6-deﬁcient (
 
Snell’s waltzer
 
; 
 
sv/sv
 
) hippo-
campus exhibits a decrease in synapse number, abnormally
short dendritic spines, and profound astrogliosis. Similarly,
cultured 
 
sv/sv
 
 hippocampal neurons display decreased
numbers of synapses and dendritic spines, and dominant-
M
 
negative disruption of Myo6 in wild-type hippocampal
neurons induces synapse loss. Importantly, we ﬁnd that
 
sv/sv
 
 hippocampal neurons display a signiﬁcant deﬁcit
in the stimulation-induced internalization of 
 
 
 
-amino-
3-hydroxy-5-methyl-4-isoxazole propionic acid–type glu-
tamate receptors (AMPARs), and that Myo6 exists in a
complex with the AMPAR, AP-2, and SAP97 in brain.
These results suggest that Myo6 plays a role in the clathrin-
mediated endocytosis of AMPARs, and that its loss leads
to alterations in synaptic structure and astrogliosis.
 
Introduction
 
In the mature brain, excitatory transmission occurs with the
presynaptic release of glutamate, which binds and activates
receptors clustered at the postsynaptic density (PSD). In the
majority of neurons, these excitatory synapses are made at
dendritic spines, or small protrusions of dendrite. It is thought
that the modulation of glutamate receptor expression at the
PSD results in long-lasting changes in synaptic strength,
though the mechanisms behind this are poorly understood
(Malinow and Malenka, 2002). Recently, it has been suggested
that F-actin, the major cytoskeletal component of the post-
synaptic terminal, is essential for this process. Indeed, depoly-
merization of F-actin has been shown to disrupt signaling
through both the 
 
 
 
-amino-3-hydroxy-5-methyl-4-isoxazole pro-
pionic acid (AMPA)–type glutamate receptor (AMPAR) and
the 
 
N
 
-methyl-
 
D
 
-aspartate–type glutamate receptor (NMDAR),
which are the two ionotropic receptors responsible for the
majority of fast glutamatergic transmission (Rosenmund and
Westbrook, 1993; Kim and Lisman, 1999). However, the link
between glutamate receptor activity and F-actin has yet to be
explored in depth.
Myosins are motor proteins that move on F-actin, using
the hydrolysis of ATP, transporting vesicles, organelles, pro-
tein complexes, and mRNA, to various sites in the cell (Mer-
mall et al., 1998). In humans, there are nearly 40 myosin genes
grouped into 12 distinct classes; together, they are essential for
a multitude of cellular processes, including endocytosis, exocy-
tosis, and cell motility (Mermall et al., 1998; Berg et al., 2001).
Underscoring their importance, mutations in myosin genes
have been linked to a variety of diseases in humans, including
deafness, blindness, and cardiac myopathy (Redowicz, 2002;
Mohiddin et al., 2004). Although multiple myosins have been
found in neurons (Bridgman, 2004), their functions there are
largely unknown. One such myosin is myosin VI (Myo6). In
nonneuronal cells, Myo6 has been implicated in clathrin-
mediated endocytosis and vesicle trafficking (Buss et al., 2001;
Hasson, 2003). Myo6 is considered unique, as it moves toward
the slow-growing (minus) ends of actin filaments (Wells et al.,
1999), which tend to be oriented toward the cell center. In con-
trast, all other native myosins studied have been shown to
move toward the fast-growing (plus) ends of F-actin. It has
been suggested that its directionality allows for Myo6 at the
plasma membrane to pull endocytic vesicles inward using force
generated by its movement on F-actin (Hasson, 2003).
Consistent with this suggestion, Myo6 has been local-
ized to sites of endocytosis in kidney-proximal tubule cells
(Biemesderfer et al., 2002), intestinal enterocytes (Heintzelman
et al., 1994), and inner ear hair cells (Hasson et al., 1997). In
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addition, Myo6 interacts with the clathrin adaptor protein AP-2
via the linker protein Dab2, and experiments using a dominant-
negative Myo6 (dnM6) show that Myo6 is essential for clath-
rin- and AP-2–mediated endocytosis, as well as for the traffick-
ing of uncoated endocytic vesicles (Buss et al., 2001; Morris et
al., 2002; Aschenbrenner et al., 2003). However, evidence of
an endocytic disruption in Myo6-deficient (
 
Snell’s waltzer
 
; 
 
sv/
sv
 
) cells is less direct. The inner ear hair cells of the 
 
sv/sv
 
mouse exhibit fused stereocilia, and this fusion may be the re-
sult of inefficient endocytosis at their base (Self et al., 1999).
In addition, recent experiments show that fibroblasts cultured
from 
 
sv/sv
 
 mice display abnormal vesicular trafficking at the
Golgi apparatus (Warner et al., 2003).
In the present study, we find that Myo6 is expressed
throughout the brain, present at synapses, and biochemically
enriched with the PSD. Myo6 association with the PSD is not
dependent on F-actin interaction. Examination of 
 
sv/sv
 
 brain
reveals decreases in synapse number and dendritic spine length
in the hippocampus, as well as widespread astrogliosis. In addi-
tion, cultured 
 
sv/sv
 
 hippocampal neurons display decreases in
both synapses and numbers of dendritic spines, and wild-type
neurons expressing dnM6 similarly display synapse loss. Inter-
estingly, we find that both AMPA- and insulin-induced AM-
PAR internalization are disrupted in hippocampal neurons
cultured from 
 
sv/sv
 
 mice. In control neurons, inhibition of
clathrin-mediated endocytosis disrupts AMPAR internalization
to the same extent. Supporting this, Myo6 exists in a complex
with the AMPAR and SAP97, a putative AMPAR trafficking
protein, in rat brain (Wu et al., 2002), and we find that this
complex also contains AP-2. This interaction is not seen with
the NMDAR, which suggests that Myo6 specifically interacts
with endocytic AMPARs. Consistent with this, no deficit is
seen in constitutive transferrin (Tf) receptor internalization in
 
sv/sv
 
 neurons. To our knowledge, these results constitute the
first time a deficit in clathrin-mediated endocytosis has been
seen in 
 
sv/sv
 
 cells.
 
Results
 
Myo6 is expressed throughout the brain
 
Immunostaining of adult mouse brain shows that Myo6 is
enriched in multiple layers of the cortex, hippocampus, and
cerebellum (Fig. 1 A). Hippocampal expression is the same
throughout areas CA1, CA2, and CA3, and the dentate gyrus,
whereas cerebellar expression is highest in the molecular layer
(Fig. 1, B and C). Myo6 is expressed at a high level in the neu-
ropil, in contrast to myelinated fiber tracts, where expression is
low. In addition to its distribution, we examined the expression
of Myo6 during brain development. Western blotting of whole
brain homogenates reveals that there is no significant change in
total brain Myo6 expression from postnatal day 1 to adulthood
(Fig. 1 D).
 
Myo6 is present at synapses and 
enriched at the PSD
 
To explore its subcellular distribution, we immunostained ma-
ture rat hippocampal neurons for Myo6. Myo6 is seen through-
out the cell, and is highly expressed at the perinuclear region
and in dendrites, where it is concentrated in discrete puncta.
These puncta partially colocalize with the synaptic marker
PSD-95, indicating that Myo6 is present at synapses (Fig. 2 A).
This partial, rather than complete, colocalization pattern is not
surprising, as myosins are dynamic and are often found in
many different subcellular regions. To examine the enrichment
of Myo6 at synapses, we performed a biochemical fraction-
ation protocol designed to isolate the PSD component from
brain. This procedure yields a synaptosome fraction, consisting
of resealed pre- and postsynaptic terminals, and a purified PSD
fraction (Dosemeci and Reese, 1993). Western blot analyses
(loaded equal protein) show that Myo6 is enriched in the PSD
fraction, though it is also present in both the homogenate and
synaptosome fractions (Fig. 2 B). To determine whether this
enrichment exists in specific brain regions, we isolated PSD
fractions from the cortex, hippocampus, and cerebellum. These
experiments show that Myo6 is enriched with the PSD in all
three regions, with the greatest enrichment seen in the cortex
(Fig. 2 B). The low expression of the NMDAR in the cerebel-
lum is consistent with previous studies (Yamada et al., 2001).
The enrichment of Myo6 at the PSD could be mediated
by its affinity for F-actin, alone. Conversely, Myo6 could inter-
act with other PSD constituents in addition to F-actin. To ex-
plore this possibility, we performed ATP extraction experi-
ments on isolated PSD fractions. For many myosins, including
Myo6, affinity for actin is decreased in the presence of ATP
(Hasson and Mooseker, 1994). PSD fractions were extracted
with buffer in the absence or presence of ATP, and the resultant
supernatant and pellet fractions were examined. ATP treatment
of isolated PSD fractions failed to solubilize the majority of
Myo6 (Fig. 2 C). This indicates that Myo6 interacts with other
proteins at the PSD, in addition to F-actin. In contrast, ATP
treatment of Triton X-100 (TX)–permeabilized synaptosomes
resulted in the release of the majority of Myo6 from the pellet
Figure 1. Myo6 expression in brain. (A–C) Adult mouse brain sections
were stained for Myo6. (A) Sagittal section shows Myo6 is expressed
throughout the brain. Higher magnification images of individual brain
regions show that Myo6 is highly expressed in (C) the cerebellar molecular
(ML) and granule cell (GCL) layers (control nonimmune IgG also shown),
and (B) hippocampal areas CA1, CA2, and CA3, and the dentate gyrus
(DG). Minimal contrast/brightness adjustment was performed. (D) West-
ern blotting of brain homogenates from mice ages postnatal day 1 to 46
(loaded equal protein) reveals that the expression of Myo6 in whole brain
does not change from birth to adulthood. Bars: (A) 1 mm; (B) 0.5 mm; (C)
0.25 mm. 
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fraction, suggesting that most synaptic Myo6 associates with
F-actin alone (Fig. 2 C).
 
Sv/sv
 
 hippocampus exhibits synaptic 
abnormalities
 
To determine whether disruption of Myo6 results in any synap-
tic deficits in vivo, we performed EM analyses on 
 
sv/sv
 
 brain.
Specifically, we examined hippocampal area CA1, as it is rich
in spiny pyramidal cell dendrites and very well characterized
with respect to dendritic ultrastructure (Harris and Landis,
1986; Hering and Sheng, 2001). The inner ear hair cell deficits
in 
 
sv/sv
 
 mice lead to a degeneration of the neurosensory epithe-
lium, resulting in deafness and severe vestibular dysfunction
(Avraham et al., 1995). Thus, to control for secondary effects in
 
sv/sv
 
 brain, we included myosin VIIa (Myo7a) mutant (
 
Shaker-1
 
;
 
sh1/sh1
 
) mice in our analyses. These mice, which express
normal levels of Myo6, are also deaf and exhibit identical spin-
ning behavior, but are unlikely to have significant central ner-
vous system defects because there is a negligible amount of
Myo7a expressed in brain (Hasson et al., 1995). We find that
Figure 2. Myo6 is partially localized to synapses and
associated with the PSD in an actin-independent manner.
(A) Hippocampal neurons (at 20 d) were costained for
Myo6 and the synapse marker PSD-95, revealing
Myo6 localization throughout the cell body and den-
drite shaft and in clusters that partially overlap with
PSD-95 puncta (arrows). Insets show enlarged regions
of dendrite. Arrowheads indicate areas of colocaliza-
tion. Bar, 10  m. (B) Western blots of homogenate (H),
synaptosome (Syn), and PSD fractions of whole brain,
cortex, cerebellum, or hippocampus (equal protein
loading) show that Myo6 is enriched in the PSD frac-
tion throughout the brain. Controls for both preparation
purity and gel loading included postsynaptically en-
riched NMDA-R1 and PSD-95, as well as presynapti-
cally enriched synaptophysin (Synphys). Lanes on the
same blot are shown separated for easier comparison.
(C) Isolated PSD and TX-permeabilized synaptosome (Syn) fractions were incubated in the presence or absence of ATP, and the pellet (P) and super-
natant (S) fractions were equal volume loaded. The majority of Myo6 in the PSD fraction, but not the synaptosome fraction, was pelleted despite ATP
treatment.
Figure 3. Sv/sv mice have fewer synapses and shorter
dendritic spines in CA1. (A) Representative images show
that sv/sv CA1 displays abnormal morphology, including
fewer synapses per square millimeter, than sv/wt CA1.
Dendrites (Den) and synapses (*) are labeled. Bars, 1
 m. (B) Dendritic spines in sv/sv CA1 are shorter than
those in sv/wt CA1. Dendritic spine heads (H) and necks
(N) are labeled. Bars, 0.25  m. Minimal contrast/
brightness adjustment was performed. (D) Quantification
of random images reveals that sv/sv CA1 has 27% fewer
synapses per square millimeter as compared with sh1/sh1
or sv/wt CA1 (*, P   0.001; nsv/sv   87, nsv/wt   57,
and nsh1/sh1   77). (C) Length measurements of multiple
dendritic spines from sv/wt,  sv/sv, and sh1/sh1 CA1
show that sv/sv CA1 dendritic spines are an average of
19% shorter than sh1/sh1 and sv/wt spines (*, P  
0.001; nsv/sv   94, nsv/wt   103, and nsh1/sh1   98). Error
bars indicate SEM. 
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the ultrastructure of 
 
sv/sv
 
 CA1 is markedly different from those
of Myo6 heterozygous (
 
sv/wt
 
) and 
 
sh1/sh1
 
 controls. A notice-
able decrease in synapses is observed, and quantification re-
veals that 
 
sv/sv
 
 mice have 27% fewer synapses per square milli-
meter of CA1 than 
 
sv/wt
 
 and 
 
sh1/sh1
 
 mice (Fig. 3 D; P 
 
 
 
0.001). In addition to synapse number, we examined the mor-
phological features of 
 
sv/sv
 
 dendritic spines. Specifically, we
measured dendritic spine lengths, head widths, neck widths,
PSD lengths, and two-dimensional surface areas in multiple im-
ages of CA1. Of these parameters, dendritic spine length was
the only measure that was significantly different, with 
 
sv/sv
 
CA1 dendritic spines 19% shorter than those of 
 
sv/wt
 
 and 
 
sh1/
sh1
 
 controls (Fig. 3 C; P 
 
 
 
 0.001).
 
Sv/sv
 
 brain displays widespread astrogliosis
 
Ultrastructural studies reveal that in addition to exhibiting syn-
aptic deficits, 
 
sv/sv
 
 neuropil is highly disordered compared
with control neuropil (Fig. 3 A). Further investigation revealed
that this is likely caused by an increased number of astrocytes
in 
 
sv/sv
 
 brain. Astrocytes can be distinguished from most other
cells by the expression of the filament protein glial fibrillary
acidic protein (GFAP). Immunoblotting of 
 
sv/sv
 
 brain shows a
fourfold increase in GFAP, as compared with 
 
sv/wt
 
 brain,
though no increase was seen in 
 
sh1/sh1
 
 brain (Fig. 4 A). In-
creased GFAP can also be detected by immunostaining of 
 
sv/sv
 
brain (Fig. 4, B and C), and the abundance of GFAP-labeled
processes seen throughout 
 
sv/sv
 
 CA1 (Fig. 4 C) may account
for its disordered appearance by EM (Fig. 3). Indeed, further
EM analyses revealed the presence of many gliofilament-con-
taining astrocytes within 
 
sv/sv
 
 CA1 (Fig. 4 D).
Astrocytes up-regulate GFAP and proliferate in response to
central nervous system injuries such as stroke, epilepsy, or neuro-
degenerative disease, a process termed astrogliosis (Little and
O’Callagha, 2001). To verify that the increased GFAP observed
in 
 
sv/sv
 
 brain was caused by an increase in GFAP per astrocyte,
and not solely by an increase in astrocyte number, we performed
flow cytometry on cells isolated from 
 
sv/sv
 
 brain. Flow cytome-
try has been reliably used to assess the proportions of different
cell types in both whole brain and culture (Tomomura et al.,
2001; Sergent-Tanguy et al., 2003). Because the level of GFAP
in 
 
sh1/sh1
 
 brain does not differ from that in 
 
sv/wt
 
 brain (Fig. 4,
A–C), we excluded this group from our flow cytometric analyses.
After isolation and staining, the proportion and mean fluores-
cence intensity of GFAP-positive (GFAP
 
 
 
) cells in each brain
were determined by cell sorting (Fig. 4 E). Analyses revealed that
 
sv/sv
 
 brain exhibits a 2.1-fold increase in the proportion of
GFAP
 
 
 
 cells (P 
 
 
 
 0.05) and a 1.7-fold increase in GFAP per
cell (P 
 
 
 
 0.02), compared with 
 
sv/wt
 
 littermates (Fig. 4 F). These
results indicate that both the astrocytic up-regulation of GFAP
and the number of astrocytes are increased in 
 
sv/sv
 
 brain.
 
Disruption of Myo6 in hippocampal neurons 
results in decreased synaptic density
 
To determine whether the synaptic deficits seen in 
 
sv/sv
 
 brain
are caused solely by astrogliosis, we examined 
 
sv/sv
 
 hippo-
campal neurons isolated in cell culture. These neurons exhibit
no obvious morphological changes, and mature to an age at
which synaptic structure can be observed. However, analyses of
synaptic density revealed that 
 
sv/sv
 
 neurons express 21% fewer
PSD-95–labeled synapses than 
 
sv/wt neurons (Fig. 5, A–C; P  
0.001). In addition, analyses of spinophilin staining revealed
that sv/sv neurons express 22% fewer spinophilin-labeled den-
dritic spines than sv/wt neurons (Fig. 5, D–F; P   0.001). It is
unlikely that this deficit is caused by altered regulation of spino-
philin, as Myo6 does not interact with spinophilin in rat brain
and levels of spinophilin are not altered in sv/sv brain (unpub-
lished data). To determine whether synapse loss could be in-
duced with acute disruption of Myo6, we examined cultured
Figure 4. Sv/sv mice display astrogliosis
throughout the brain. (A) Western blots of sv/wt,
sv/sv, and sh1/sh1 brain homogenates,
equal protein loaded, reveal that GFAP is in-
creased fourfold in sv/sv versus sv/wt brain.
Densitometric analysis compared the ratios of
GFAP to actin between samples. Lanes between
those shown were omitted. (B and C) Sv/sv,
sv/wt, and sh1/sh1 brain sections were incu-
bated with anti-GFAP, and either peroxidase-
(B) or fluorescence (C)-conjugated secondary
antibody. Representative images of cerebellum
(B) and hippocampus (C) depict the greater
GFAP immunoreactivity seen in sv/sv versus
sv/wt and sh1/sh1 brains. Granule cell (B, GCL)
and molecular layers (B, ML) of the cerebellum
and area CA1 of the hippocampus (C) are
labeled. Bars: (B) 0.25 mm; (C) 20  m. Minimal
contrast/brightness adjustment was performed.
(D) Activated astrocyte exhibiting prominent
gliofilaments (GF) characteristic of sv/sv neuro-
pil.  Swollen mitochondria (arrowheads) are
seen in surrounding cells. Bar, 1  m. (E) Cells
isolated from sv/wt or sv/sv brains were ana-
lyzed by flow cytometry. Unstained cells (open
peaks) were compared with labeled cells
(shaded peaks) and used to determine background fluorescence (not within the GFAP  region). (F) The proportion of cells within the GFAP  range and
the mean label intensity within this range were compared, and reveal that sv/sv mice have a 2.1-fold increase in GFAP  astrocytes (*, P   0.05, n   4
each) per 100,000 cells and a 1.7-fold increase in GFAP per cell (*, P   0.02, n   4 each). Error bars indicate SEM.MYOSIN VI AND POSTSYNAPTIC RECEPTOR TRAFFICKING • OSTERWEIL ET AL. 333
hippocampal neurons expressing an EGFP-tagged dnM6 (Fig. 5
Q). This dnM6 has been shown to specifically disrupt native
Myo6 function in nonneuronal cells (Aschenbrenner et al.,
2003). In hippocampal neurons, dnM6 localizes to discrete clus-
ters throughout the dendrites and cell bodies (Fig. 5 J), which is
consistent with endogenous Myo6 staining (Fig. 2 A). We find
that neurons expressing dnM6 have 39% fewer PSD-95–labeled
synapses, as compared with untransfected neurons in the same
dish (Fig. 5, G–K; P   0.001). Consistent with this, dnM6-
expressing neurons display a 41% decrease in synaptophysin-
labeled synapses, as compared with neurons expressing EGFP
alone (Fig. 5, L–P; P   0.001). The greater synapse loss seen in
dnM6-expressing, versus sv/sv, neurons may reflect the differ-
ence between an acute versus chronic loss of Myo6 function. In-
deed, mature neurons transfected with dnM6 are not likely to
develop the compensatory mechanisms that are developed by
sv/sv neurons. These results suggest that Myo6 function is im-
portant for mature hippocampal synapses.
Myo6 interacts with the AMPAR, AP-2, 
and SAP97 in rat brain
The abnormalities seen in sv/sv neurons prompted us to investi-
gate possible roles for Myo6 at the PSD. At stimulated synapses,
AMPARs undergo regulated, clathrin- and AP-2–mediated en-
docytosis (Carroll et al., 1999; Luscher et al., 1999). Given its
proposed function in nonneuronal cells and its association with
SAP97 (Wu et al., 2002), we questioned whether Myo6 func-
tions in AMPAR endocytosis. To explore this, we performed
immunoprecipitation (IP) experiments from a deoxycholate (DOC)-
extracted, dendrite-rich fraction of rat brain. The use of DOC
was necessary, given the insolubility of PSD proteins; however,
DOC may interfere with some protein–protein interactions
(Naisbitt et al., 2000). Despite these conditions, Myo6 coimmu-
noprecipitates with both the GluR1 and GluR2 subunits of the
AMPAR in this extract (Fig. 6 A). This complex also contains
SAP97 and AP-2. Interestingly, this interaction is specific, as
Myo6 does not coimmunoprecipitate with the NR2B and NR1
subunits of the NMDAR, despite the presence of SAP97 (Fig. 6
A). Supporting these data, IP of SAP97 brings down Myo6, AP-2,
and the AMPAR (Fig. 6 B). These results indicate that Myo6
specifically interacts with endocytic AMPARs, and that this in-
teraction can withstand the presence of an ionic detergent.
Sv/sv neurons display defective AMPAR 
internalization
To directly assess whether Myo6 plays a role in AMPAR en-
docytosis, we used a well-characterized assay system designed
to measure stimulus-induced AMPAR internalization in mature
Figure 5. Myo6-deficient neurons have
fewer synapses and dendritic spines. (A–F)
Hippocampal neurons (at 14–21 d) from sv/
sv and sv/wt embryos were stained for PSD-
95 or spinophilin (Spnph). Quantification re-
veals that sv/sv neurons have 21% fewer PSD-
95–labeled synapses (*, P   0.001; nsv/sv  
147 and nsv/wt   160) and 22% fewer den-
dritic spines (*, P   0.001; nsv/sv   165 and
nsv/wt   126) than sv/wt neurons. (G–P) Rat
hippocampal neurons (at 14 d) were trans-
fected with dnM6 or EGFP. DnM6 expression
is concentrated at the cell body and in bright
clusters throughout the dendrite. Cultures were
stained for PSD-95 (G–J) or synaptophysin
(Synphy; L–O). Minimal contrast/brightness
adjustment was performed. Quantification re-
vealed the following: neurons expressing
dnM6 have (K) 39% fewer PSD-95–labeled
synapses than untransfected neurons in the
same dish (*, P   0.001; ndn   146 and
nun   148) and (P) 41% fewer synaptophysin-
labeled synapses than neurons expressing
EGFP (*, P   0.001; ndn   126 and nGFP  
93). (Q) Schematic of Myo6 domain structure.
DnM6 contains an EGFP tag NH2-terminal to
the tail of Myo6. Bars, 10  m. Error bars in-
dicate SEM.JCB • VOLUME 168 • NUMBER 2 • 2005 334
hippocampal neurons (Carroll et al., 1999; Snyder et al., 2001).
Sv/sv and sv/wt hippocampal neurons were incubated with anti-
body specific for the extracellular domain of the GluR1 subunit
of the AMPAR and stimulated with 100  M AMPA for 15
min. After stimulation, surface-bound antibody was removed
with a strip buffer, and the neurons were fixed, permeabilized,
and incubated with a fluorescent secondary antibody. This pro-
tocol results in visualization of only the antibody-bound recep-
tors internalized during AMPA treatment (Carroll et al., 1999;
Snyder et al., 2001). Consistent with previous reports (Carroll
et al., 1999; Lin et al., 2000), our control group (sv/wt neurons)
displays an 83% increase in AMPAR internalization after
AMPA treatment (Fig. 7, G, H, and K; P   0.001). However,
in sv/sv neurons, no AMPAR internalization was observed after
AMPA stimulation (Fig. 7, I–K). To further explore the deficit
seen in sv/sv neurons, we repeated our experiments using insu-
lin, which has also been shown to induce AMPAR endocytosis
Figure 6. Myo6 exists in a complex with the AM-
PAR, AP-2, and SAP97 in rat brain. (A) IP of the
AMPAR from DOC-extracted rat brain brings down
Myo6, SAP97, and AP-2. Both GluR2 and GluR1
subunits are present in this complex. Myo6 does not
coimmunoprecipitate with the NR2B and NR1 sub-
units of the NMDAR, despite the presence of SAP97
in this complex. (B) SAP97 immunoprecipitates a
complex containing Myo6, AP-2, and the AMPAR.
IPs done with equal amounts of nonimmune IgG are
devoid of Myo6. Input lanes are 0.1 vol relative to
IP lanes.
Figure 7. Sv/sv hippocampal neurons display dysfunctional AMPA-induced
AMPAR internalization. (A–F) Total GluR1 (nsv/wt   183 and nsv/sv   173)
or GluR2 (nsv/sv   114 and nsv/wt   115) was measured in unstimulated
neurons by permeabilization and incubation with secondary antibody,
and both were found to be the same in sv/wt and sv/sv neurons. (G–J)
GluR1 antibody was applied for 10 min, followed by 1  M TTX   100
 M AMPA for 15 min. Internalized AMPARs were assessed after incuba-
tion with acetic acid followed by permeabilization and secondary incuba-
tion. (K) AMPA treatment induces an 83% increase in internalized AM-
PARs in sv/wt neurons (*, P   0.001; ncon   171 and nAMPA   156), but
no increase in sv/sv neurons (ncon   148 and nAMPA   125). Bars, 10  m.
Error bars indicate SEM. Insets show (left) enlarged areas of dendrite and
(right) puncta counted (red) based on thresholding of images. Minimal
contrast/brightness adjustment was performed.
Figure 8. Sv/sv hippocampal neurons display dysfunctional insulin-
induced AMPAR internalization identical to the disruption of clathrin-
mediated endocytosis. (A–F) Anti-GluR1 was applied for 10 min, followed
by 1  M TTX   10  M insulin for 15 min. Clathrin-mediated endocytosis
was disrupted with a 10-min incubation in 0.45 M sucrose before stimulation.
Internalized AMPARs were assessed after incubation with acetic acid
followed by permeabilization and secondary incubation. Minimal con-
trast/brightness was performed. Insets show puncta counted (red) based
on thresholding of images. (G) Insulin treatment induces a 106% increase
in internalized AMPARs in sv/wt neurons (*, P   0.001; ncon   139 and
nins   170), but no change in sv/sv neurons (ncon   161 and nins   110).
(E and F) Inhibition of clathrin-mediated endocytosis diminishes AMPAR in-
ternalization to control levels in insulin-stimulated sv/wt neurons (nins   suc  
188), but does not affect insulin-stimulated sv/sv neurons (nins   suc   159).
Insets show (left) enlarged areas of dendrite and (right) puncta counted
based on thresholding of images. Minimal contrast/brightness was per-
formed. (H–J) Dendritic uptake of Alexa 568–labeled Tf is similar in sv/wt
and sv/sv neurons (nsv/sv   273 and nsv/wt   215). Insets show (left) en-
larged areas of dendrite and (right) puncta counted (red) based on thresh-
olding of images. Minimal contrast/brightness was performed. Bars, 10
 m. Error bars indicate SEM.MYOSIN VI AND POSTSYNAPTIC RECEPTOR TRAFFICKING • OSTERWEIL ET AL. 335
in a clathrin-dependent manner (Lin et al., 2000; Man et al.,
2000). A 15-min stimulation with 10  M insulin resulted in a
106% increase in AMPAR internalization in sv/wt neurons
(Fig. 8, A, B, and G; P   0.001). AMPAR internalization in in-
sulin-treated  sv/sv neurons, however, was no different from
that in unstimulated neurons (Fig. 8, C, D, and G).
To determine whether this deficit in AMPAR internaliza-
tion is caused by a decreased steady-state expression of GluR1,
we examined total GluR1 levels in sv/sv and sv/wt neurons.
Analyses revealed no difference in total GluR1 levels between
sv/sv and sv/wt neurons (Fig. 7, A–C). In addition, we mea-
sured the levels of surface-expressed GluR1 in sv/sv neurons at
steady state, and found that they do not differ from levels in sv/
wt neurons (unpublished data). The internalization of GluR1 is
likely mediated by its association with the GluR2 subunit of
the AMPAR (Man et al., 2000). Therefore, we examined the
steady-state level of GluR2 in sv/sv hippocampal neurons. Sim-
ilar to those of GluR1, total GluR2 levels are not different be-
tween sv/sv and sv/wt neurons (Fig. 7, D–F).
It is reasonable to hypothesize that disruption of Myo6
trafficking of clathrin-coated vesicles is responsible for the
dysfunctional AMPAR internalization seen in sv/sv neurons.
To verify that our assay specifically measured clathrin-medi-
ated endocytosis, we pretreated neurons with 0.45 M hyper-
tonic sucrose, and stimulated them again with insulin. This
treatment has been shown to disrupt clathrin-mediated endocy-
tosis and abolish AMPAR internalization in hippocampal neu-
rons (Hansen et al., 1993; Man et al., 2000). Consistent with
previous findings, sucrose preincubation reduced the AMPAR
internalization in insulin-treated sv/wt neurons to background
levels (Fig. 8, E and G). In addition, sucrose preincubation had
no further effect on sv/sv neurons (Fig. 8, F and G).
This result confirms that our assay system is specifically
measuring clathrin-mediated endocytosis, and suggests that the
deficit seen in sv/sv neurons is caused by a deficit in clathrin-
mediated endocytosis. However, if Myo6 were essential for
all clathrin-mediated endocytosis at synapses, greater deficits
would be expected. To explore whether Myo6 disruption re-
sults in a general deficit in clathrin-mediated endocytosis, we
examined Alexa 568–labeled Tf uptake in sv/sv dendrites. In-
terestingly, dendritic uptake of Alexa 568–labeled Tf is the
same in sv/sv and sv/wt neurons (Fig. 8, H–J), which suggests
that the involvement of Myo6 in clathrin-mediated endocytosis
is specific for certain targets, such as the AMPAR.
Discussion
Myosin transport of proteins and organelles along F-actin un-
derlies the most basic of cellular processes. At the actin-rich
dendritic spine, this transport is especially important for the
spatial and temporal coordination of glutamate receptors and
signaling molecules that participate in excitatory synaptic
transmission. The localization of Myo6 at the PSD, with its
unique properties, has significant implications for synaptic
function. Our results show that a loss of Myo6 leads to a de-
crease in synaptic density and dendritic spine abnormalities in
whole brain and isolated hippocampal neurons. Similarly, hip-
pocampal neurons expressing dnM6 exhibit a decrease in syn-
apse number, which suggests that acute Myo6 disruption at ma-
ture synapses results in their elimination. In addition, sv/sv
brain exhibits widespread astrogliosis. Finally, we find that sv/
sv neurons display a specific deficit in the stimulation-induced
internalization of AMPARs, which is mimicked by the disrup-
tion of clathrin-mediated endocytosis in sv/wt neurons. Sup-
porting this, Myo6 exists in a complex with the AMPAR,
SAP97, and AP-2 in rat brain.
Myo6 and AMPAR internalization
The results reported here indicate that Myo6 links AMPAR in-
ternalization to the postsynaptic cytoskeleton. Consistent with
this, EM imaging of myosin-decorated F-actin in dendritic
spines suggests that it is polarized, with plus ends pointed to-
ward the plasma membrane (Fifkova and Delay, 1982). This
arrangement would allow minus end–directed Myo6 to pull en-
docytic AMPARs down from the dendritic spine surface. Sup-
porting this, our results demonstrate that Myo6 exists in a com-
plex with AP-2, which has previously been shown to play a
role in AMPAR internalization (Carroll et al., 1999). Further-
more, our results suggest that Myo6 interacts specifically with
endocytic AMPARs, as it does not coimmunoprecipitate with
the NMDAR in rat brain. Consistent with this, constitutive Tf
uptake is not disrupted in sv/sv neurons, which suggests that
Myo6 does not function in all clathrin-mediated endocytosis
events at the PSD. Instead, Myo6 may selectively target clath-
rin pits containing AMPARs. Such specificity could be medi-
ated by specialized adaptor proteins such as SAP97 and AP-2.
The regulation of AMPAR expression at the PSD is
thought to be an important component of synaptic plasticity, or
the long-term modification of synaptic strength, which has
been linked to learning and memory (Malinow and Malenka,
2002). Recent evidence suggests that the coordinated endo-
cytosis of AMPARs directly mediates long-term depression
(LTD), a form of synaptic plasticity. Induction of LTD in hip-
pocampal neurons in vitro and in vivo results in decreased AM-
PAR expression at the plasma membrane (Heynen et al., 2000).
Furthermore, inhibition of clathrin-mediated endocytosis of
AMPARs blocks the induction of LTD in hippocampal neurons
(Luscher et al., 1999; Man et al., 2000). Given this, our results
suggest that the Myo6-dependent internalization of AMPARs
may play an important role in the induction or maintenance
of LTD.
The loss of synapses observed in sv/sv neurons may ap-
pear to be inconsistent with unaltered levels of GluR1 and
GluR2 at steady state. However, decreased synapse number in
sv/sv neurons may result in a redistribution of AMPARs to ex-
trasynaptic sites without affecting total AMPAR number. In-
deed, overexpression of PSD-95 causes an increase in synaptic
AMPARs without altering the overall expression of AMPARs
at the surface, whereas overexpression of the protein stargazin
causes an increase in extrasynaptic AMPARs without changing
the number of synaptic AMPARs (Schnell et al., 2002). In
addition, disruption of F-actin in cultured neurons has been
shown to lead to a dramatic decrease in the number of synaptic
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suggesting that AMPAR trafficking occurs independent of the
synapse (Allison et al., 1998). Thus, the synapse loss observed
in sv/sv neurons would not necessarily be reflected in an over-
all decrease in AMPAR number.
Abnormalities in sv/sv brain
The synaptic deficits and astrogliosis observed in sv/sv brain are
intriguing, and how they result from a loss of Myo6 is unclear.
There may be interactions of Myo6 with proteins other than the
AMPAR at the PSD, and the loss of these might contribute to
the deficits observed in sv/sv brain. In addition, it is important
to note that Myo6 has been localized to axons in developing
neurons (Suter et al., 2000), and our results indicate that Myo6
expression is not restricted to the PSD at adult synapses (Fig. 2
C). Thus, it is possible that our results may partially reflect a
loss of Myo6 function in the presynaptic terminal.
However, there is much evidence to suggest that dysfunc-
tional glutamate receptor regulation results in abnormalities
similar to those seen in sv/sv brain. Specifically, inefficient in-
ternalization of AMPARs, as is seen in sv/sv neurons, has been
shown to result in increased excitatory current in hippocampal
slices (Luscher et al., 1999). Such excessive activation of
glutamate receptors has in turn been shown to lead to dendritic
spine loss within 10 min of agonist application, even at suble-
thal levels (Halpain et al., 1998; Hasbani et al., 2001). Consis-
tent with this, dendritic spine loss and decreased dendritic spine
length are seen in cases of epilepsy, which is a disorder charac-
terized by excessive excitatory signaling (Fiala et al., 2002). In
addition, specific inhibition of AMPAR signaling has been
shown to lead to both loss and shortening of dendritic spines
(McKinney et al., 1999). Astrogliosis is also associated with
excessive glutamatergic signaling. Injection of NMDA (Bur-
trum and Silverstein, 1993) or kainic acid (Chen et al., 2002) in
rodents results in robust and sustained astrogliosis. Supporting
this, astrogliosis is commonly seen in cases of epilepsy (Pit-
kanen and Sutula, 2002).
Despite an increase in astrocyte number, we do not see an
appreciable difference in the size of sv/sv brain. This is consis-
tent with studies showing that astrogliosis does not necessarily
correlate with an increase in brain volume (Sykova et al.,
2002). Instead, astrocytes may occupy space that once con-
tained neurons, which have since degenerated. Indeed, our EM
analyses reveal features of cellular degeneration in sv/sv neuro-
pil, such as swollen mitochondria (Fig. 4 D). Interestingly,
swollen mitochondria often signify dysfunctional calcium reg-
ulation, and can be induced in cultured neurons with excessive
glutamate application (Isaev et al., 1996). Further investigation
of the astrogliosis in sv/sv brain is currently underway.
Materials and methods
Antibodies
10  g/ml anti-Myo6 was raised against Myo6 tail (Hasson and Moo-
seker, 1994). Antispinophilin (1:1,000) was a gift from P. Allen (Yale
University, New Haven, CT). The following commercial antibodies were
used: nonimmune IgG (Jackson ImmunoResearch Laboratories); mAbs to
synaptophysin (2  g/ml; CHEMICON International), PSD-95 (2  g/ml;
Upstate Biotechnology), NR1 (BD Biosciences), GluR2 (CHEMICON Inter-
national), SAP97 (StressGen Biotechnologies),  -adaptin (BD Biosciences),
actin (CHEMICON International), and GFAP (1:500; CHEMICON Inter-
national); polyclonal antibodies to GluR1 (Oncogene Research Products),
GluR2/3 (Upstate Biotechnology), NR2B (Upstate Biotechnology), and
GFAP (1:1,000; CHEMICON International); and goat anti–mouse Alexa
488, goat anti–rabbit (GaR) Alexa 568, and GaR Alexa 488 (1:500, ex-
cept for internalization assays; Molecular Probes, Inc.).
Mice
Sv/wt (Myo6
sv/J) and sh1/wt (Myo7a
sh1-8J/J) mice were purchased from
The Jackson Laboratory, and colonies of both were established. Original
heterozygous mice were bred to produce homozygous mice. As homozy-
gous mice do not breed, all animals used for experiments were obtained
through homozygous/heterozygous breeding pairs. With the exception of
those used in hippocampal cultures, all mice used were male, to avoid es-
trogen-related dendritic spine changes that occur during estrus (Woolley
and Schwartzkroin, 1998), and age-matched within each experiment. All
experimental protocols have been approved by the Yale Institutional Ani-
mal Care and Use Committee.
Immunohistochemistry
1-yr-old C57/B6J mice (The Jackson Laboratory) were perfuse-fixed (at RT;
4% PFA/PBS; Electron Microscopy Sciences). Frozen 10- m sections were
taken with a freezing microtome, and 5- m paraffin sections were deparaf-
finized and processed for antigen retrieval as described previously (Shi et
al., 1997). Sections were incubated in block buffer (BB; 5% normal goat se-
rum [Sigma-Aldrich], 5% BSA [Sigma-Aldrich], and 10% horse serum [Hy-
clone] in PBS) with 1% TX for 1 h at 37 C and primary antibody (or nonim-
mune IgG) in BB/0.1% TX for 1 h at 37 C or overnight at 4 C, and stained
with the VECTASTAIN Elite ABC peroxidase system (Vector Laboratories) or
GaR Alexa 568 in BB/0.1% TX for 30 min at RT.
PSD and synaptosome preparations
PSD preparations were performed at 4 C as described previously (Dose-
meci and Reese, 1993). All solutions contained 1 mM Pefabloc and 1 mM
DTT. In brief, C57/B6J mouse brains or Lewis rat brain regions were ho-
mogenized in 0.32 M sucrose with a Teflon dounce and cleared at 1,400 g,
and the supernatant was spun at 13,800 g for 10 min. The pellet was
resuspended and run over a discontinuous sucrose gradient (1.2 M/1 M/
0.85 M) at 82,500 g for 2 h, and the 1.2 M/1 M interface (synaptosome
fraction) was collected, solubilized in 0.5% TX for 15 min at RT, and spun
at 36,000 g for 30 min. The pellet was then run over a second gradient
(2.1 M/1.5 M/1 M) for 20 min at 200,000 g, and the 2.1 M/1.5 M in-
terface was collected, incubated with 75 mM KCl and 0.5% TX, run over
a 2.1-M sucrose cushion, washed with 20 mM Hepes, and run over a sec-
ond cushion.
ATP extractions
Isolated synaptosome and PSD fractions were resuspended in buffer A (1
mM EGTA, 75 mM KCl, 2.5 mM MgCl2, 1 mM DTT, 1 mM Pefabloc, and
20 mM imidazole, pH 7.2) or in 50 mM Mg-ATP (50 mM ATP and 50 mM
MgCl2), or dH2O was added (1:10; for synaptosomes, 0.1% TX was also
added), and they were incubated for 30 min at 37 C. Fractions were then
spun at 200,000 g for 30 min, the supernatants were removed, the pellets
were resuspended to their original volumes with buffer A, and both fractions
were loaded equal volume. These experiments were repeated three times.
IP
DOC-solubilized extracts were made from adult rat brain, essentially as
described previously (Naisbitt et al., 2000). Extracts were precleared with
0.1 vol protein A–Sepharose (Amersham Biosciences) for 1 h at 4 C and
incubated with 10  g/ml of antibodies to GluR2/3, NR2B, or SAP97, or
with nonimmune IgG, overnight at 4 C. Protein A–Sepharose was then
added (1:10), and the extracts were incubated for 1 h at 4 C. Pellets were
washed five times for 1 min with HSIPB (10  g/ml BSA, 1 mM DTT,1 mM
EGTA, 200 mM KCl, 5 mM Mg-ATP, 1 mM Pefabloc, 50 mM Tris, pH
7.4, and 0.1% TX) and processed for SDS-PAGE.
Western blotting
The protein concentration of each sample was determined using a colori-
metric assay (BCA; Pierce Chemical Co.) and densitometric analysis of a
Coomassie blue–stained gel that was performed using the one-dimen-
sional gel analysis tool in Metamorph 5.0 (Universal Imaging Corp.).
Samples were run on 5–20%-gradient SDS-PAGE gels and transferred (at
85 V for 2–4 h at 4 C) to nitrocellulose. Immunoblotting was performed
with the appropriate primary antibodies and ECL, according to the kit
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scanned blot films using the gel analyzer tool in Image J. The density of
the GFAP band was expressed as a percent of the actin band in the same
lane, and this ratio was compared among sv/wt, sv/sv, and sh1/sh1
samples.
Immunocytochemistry
Cultures of rat hippocampal neurons were made as described previously
(Goslin and Banker, 1991). In brief, embryonic day 18 rat hippocampus
was dissected, incubated in 0.25% trypsin at 37 C, and dissociated by
trituration, and 100,000–200,000 cells/ml were plated onto 1 mg/ml
poly-L-lysine–coated glass coverslips for 3 h at 37 C. The coverslips were
then inverted over a monolayer of glial cells in modified N2 medium and
kept in vitro for 14–21 d. For staining, live-cell extraction was performed
to enhance staining of nonsoluble elements (i.e., PSD components), as de-
scribed previously (Suter et al., 2000). In brief, coverslips were incubated
in 0.05% saponin in PHEM buffer (60 mM Pipes, 25 mM Hepes, pH 7, 5
mM EGTA, and 3% sucrose) for 30 s at 37 C, 4% PFA/0.1% TX/PHEM
for 10 min at 37 C, 4% PFA/PHEM for 30 min at 37 C, BB for 30 min at
RT, primary antibody in BB overnight at 4 C, and secondary antibody in
BB for 30 min at RT, and were mounted with ProLong antifade (Molecular
Probes, Inc.). For synaptophysin staining, cells were fixed in 4% PFA/4%
sucrose/PBS for 15 min at 37 C, permeabilized in 0.1% TX/BB for 10
min at RT, and processed for staining as just described.
Internalization assays
Hippocampal neurons from sv/sv and sv/wt embryos were made as de-
scribed in the Immunocytochemistry section. All coverslips used were
matched for cell density and branching immediately before experimenta-
tion. When needed, media were changed to insulin-free or Tf-free modi-
fied N2 for at least 8 h. Cells were incubated in 5  g/ml anti-GluR1 for
10 min at 37 C and stimulated with 100  M AMPA   1  M tetrodotoxin
(TTX; Tocris Cookson, Inc.), 10  M insulin (Sigma-Aldrich)   1  M TTX,
or N2   1  M TTX, for 15 min at 37 C. Clathrin-mediated endocytosis
was disrupted with 0.45 M sucrose for 10 min at 37 C before stimulation.
For Tf experiments, coverslips were stimulated with 50  M Alexa 568 Tf
for 10 min at 37 C. Coverslips were then incubated with ice-cold PBS for
1 min (to stop endocytosis) and 0.5 M ice-cold NaCl/0.2 M acetic acid,
pH 3.5, for 4 min, washed, fixed, and permeabilized. For AMPA and in-
sulin experiments, coverslips were incubated with GaR Alexa 488 (1:200)
in BB for 1 h at RT. To determine total GluR1 and GluR2 levels, unstimu-
lated coverslips were stained in the same way, but without prior exposure
to NaCl/acetic acid. Surface GluR1 levels were determined by omitting
both the NaCl/acetic acid and permeabilization steps.
Cloning and transfection
The Myo6 tail (starting at the coiled coil; nucleotides 5212–4191; avail-
able from GenBank/EMBL/DDBJ under accession no. NM_004999) was
obtained by PCR (Herculase; Stratagene) from a cDNA library of human
intestinal epithelium. Products were digested with KpnI and BamHI (New
England Biolabs, Inc.), cloned into pEGFP-C1 (CLONTECH Laboratories,
Inc.), expressed in XL-1 Blue bacteria (Stratagene), and sequenced (Keck
Facility, Yale University, New Haven, CT). The resulting construct was
transfected into 14-d-old rat hippocampal cultures (Immunocytochemistry
section) using lipofectamine 2000 (Invitrogen), and pEGFP-C1 was simul-
taneously transfected into sister cultures. Cells were returned to glia after 5 h,
and left for an additional 19–24 h before staining.
Imaging and data analysis
Sections were imaged with Plan Apo UW 1 /0.04 and Plan Apo 4 /
0.2 objectives (Nikon) on an Eclipse microscope (model E800; Nikon) us-
ing SPOT imaging equipment and software (SPOT Image Corporation), or
with a Plan Apo Chromat 40 /1 objective (Carl Zeiss MicroImaging,
Inc.) on a laser scanning confocal microscope (model MRC-1024; Bio-Rad
Laboratories), using identical settings for each section in a group. With the
exception of those stained for synaptophysin (imaged using a Plan Fluor
20 /0.5 objective [Nikon]), cell staining was imaged with a Plan Apo
Chromat 63 /1.4 objective (Carl Zeiss MicroImaging, Inc.) on the afore-
mentioned confocal microscope, using identical settings for each group.
Contrast/brightness enhancement and enlargement were done on ob-
tained images only in parallel with control images, using Adobe Photo-
shop 5.5. In some cases, the background between images was normal-
ized before adjustments were made. For internalization assays, images
were taken of 10 randomly selected fields (1–4 cells/field) per coverslip,
from three to five independent experiments. Cells from five different trans-
fection experiments were analyzed. Only healthy, process-bearing cells
were examined. Using Image J tracing and threshold tools, dendrite length
was measured and puncta at least twofold brighter than the background
dendrite, with an area of at least five pixels, were counted. These parame-
ters were set based on previous work (Carroll et al., 1999), and we as-
sert, based on careful examination of different parameter definitions, that
they accurately reflect the receptor clusters involved in regulated AMPAR
endocytosis. In almost all cases, the dendrites measured were primary
branches analyzed from the base to the edge of the visual field. In all ex-
periments, t tests were performed on normalized data to obtain p-values.
EM
All reagents used were obtained from Electron Microscopy Sciences. Four
1–2-yr-old mice per group were perfuse-fixed as described in the Immunocy-
tochemistry section. CA1 regions (from both hemispheres) were dissected,
postfixed in 4% gluteraldehyde/0.1 M sodium phosphate buffer, pH 7.4,
overnight at 4 C, washed, immersed in 1% osmium tetraoxide/0.1 M phos-
phate buffer, pH 6, for 1 h on ice, washed, dehydrated through ethanol,
and embedded in Polybed resin. Thin sections were mounted on copper
grids, stained, and imaged on an electron microscope (model EM-10; Carl
Zeiss MicroImaging, Inc.). Negatives of multiple random 8,000  fields
were scanned into Adobe Photoshop 5.5, randomized, and analyzed with
Image J. Synapses, identified as dark PSDs opposed to at least three presyn-
aptic vesicles, were counted with the aid of the contrast-adjust and magnifi-
cation tools in Image J. Images that contained areas devoid of tissue, or that
were occluded by contrast or staining artifacts, were discarded. Dendritic
spines were identified as dendritic extensions rich in F-actin, devoid of mi-
crotubules, and possessing PSDs at their surfaces (Hering and Sheng,
2001). Dendritic spine lengths (from PSD to base), head widths (at widest
point), average neck widths, PSD lengths, and surface areas (on a two-
dimensional image) were measured using the tracing tools in Image J. Only
those spines that were completely longitudinally sectioned, with a clearly
visible connection to the dendrite shaft, were measured.
Flow cytometry
Adult (6–10 mo old) sv/wt or sv/sv brains (n   4 each) were processed
for flow cytometry based on previously described protocols (Tomomura et
al., 2001; Sergent-Tanguy et al., 2003). In brief, brains were minced with
a razor and incubated in 0.25% trypsin in HBSS (GIBCO BRL)/33 mM
glucose for 15 min at 37 C, FBS (GIBCO BRL) was added to 10% for 10
min at 37 C, and the mixture was passed through a cell strainer (70- m
pore size; BD Flacon). The flow through was allowed to settle, and the su-
pernatant was decanted. After spinning for 7 min at 200 g, cell pellets
were resuspended and incubated in 2% PFA, 0.1% TX in BB, BB, anti-
GFAP in BB, and goat anti–mouse Alexa 488 (1:200) in BB, and ana-
lyzed in 2% FBS/PBS on a FACScalibur, using Cellquest software (Becton
Dickinson) as described previously (Sergent-Tanguy et al., 2003). In brief,
for each sample, dead cells and debris were gated out based on size and
granularity, 100,000 Alexa 488–labeled cells were counted, and histo-
grams of normalized cell number versus fluorescence intensity were cre-
ated. Positive label was differentiated from background fluorescence
based on unstained cells, or cells labeled with nonimmune IgG. Our re-
sults were expressed as the proportion of GFAP  cells in the brain isolate
and the average GFAP label intensity per cell.
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